title: The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolism.
authors.affiliation: Pharmacy Services, Hartford Hospital, 80 Seymour St., Hartford, CT 06102, USA. Electronic address: Lindsay.Hom@hhchealth.org.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Hom
authors.affiliation: University of Connecticut School of Pharmacy, Department of Pharmacy Practice, 69 N. Eagleville Rd., Unit 3092, Storrs, CT 06269, USA. Electronic address: Diana.sobieraj@uconn.edu.
authors.forename: Diana M
authors.initials: DM
authors.lastname: Sobieraj
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission / Q000639:trends; D010865:Pilot Projects; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000008:administration & dosage*; D054556:Venous Thromboembolism / Q000175:diagnosis* / Q000188:drug therapy*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D000069552:Rivaroxaban
keywords: Anticoagulant; Rivaroxaban; Venous thromboembolism